Search results
Novavax (NVAX) Seeks FDA Nod for Updated COVID-19 Vaccine
Zacks via Yahoo Finance· 6 days agoNovavax (NVAX) seeks FDA???s approval to update its COVID-19vaccine for the 2024-2025 fall season...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 2 days agoNovavax. Last year, Novavax lost $5.41 per share and had $983.7 million in sales. This year, Wall...
Novavax’s South African Phase IIb COVID-19 vaccine trial likely to reveal results within next...
Pharmaceutical Technology via Yahoo Finance· 5 days agoSouth Africa’s existing regulatory, consent and ethics frameworks around HIV vaccine trial investigations helped with regards to quick initiation and straightforward progress ...
Insider Sale: Director James Young Sells Shares of Novavax Inc (NVAX)
GuruFocus.com via Yahoo Finance· 21 hours agoOn June 18, 2024, James Young, Director at Novavax Inc (NASDAQ:NVAX), executed a sale of 7,500...
Novavax (NVAX) Ascends While Market Falls: Some Facts to Note
Zacks· 3 days agoFree Report) closed the most recent trading day at $14.06, moving +1.99% from the previous trading session. The stock exceeded the S&P 500, which registered a loss of 0.25% for the day. Heading ...
The FDA Now Wants Fall COVID Vaccines to Target KP.2—But Not All Manufacturers Can Pivot
Verywell Health via Yahoo News· 2 days agoLess than a week after telling COVID-19 vaccine manufacturers to target the JN.1 variant this fall,...
A Synergy Of Excellence: Novavax-Mabion Partnership During Unprecedented Times Amid The Covid-19...
BioresearchOnline· 3 days agoNovavax's COVID-19 vaccine, Nuvaxovid, was developed in record time with the support of Mabion, a...
COVID-19 is surging. Time to mask up or get a booster? What a Boise medical expert says
Idaho Statesman McClatchy via AOL· 2 days agoBooster shots improve immunity Pate urges people to stay up to date with COVID-19 vaccines. The...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 2 days agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
Jim Cramer Says He's 'Going To Have To Wait' On SoFi, But Recommends This 'Great Little Industrial...
Benzinga· 6 days agoOn CNBC's “Mad Money Lightning Round,” Jim Cramer said he still can't recommend Twilio TWLO. On June...